WebIn recent years, research has been conducted on delivery systems for CpG ODNs using nanoparticles (NPs). The advantages of NP-based delivery of CpG ODN include (1) it can protect CpG ODN from DNase, (2) it can retain CpG ODN inside the body for a long period of time, (3) it can improve the cellular uptake efficiency of CpG ODN, and (4) it can ... WebPEI-HA/CpG nanoparticles also induced enhanced local and systemic cellular immune responses. These immune responses did not decay over six months of observation postimmunization. PEI and CpG synergized these comprehensive immune responses. Thus, the PEI-HA/CpG nanoparticle is a potential cross-protective influenza vaccine candidate.
Nanoparticle-enhanced nasal flu vaccine delivers promising early …
WebThese TEG modified CpG-AuNP complexes induced macrophage and dendritic cell tumor infiltration, significantly inhibited tumor growth, and promoted survival in mice when … WebThree main types of CpGs have been described: the multimeric CpG-A (or D-type) stimulates plasmacytoid DCs to secrete IFN-α; CpG-B (or K-type) induces B cells and … nitos blackheath
The CpG molecular structure controls the mineralization of …
WebNov 1, 2024 · CpG oligodeoxynucleotides (CpGs) can induce an anti-tumor immune response, but also uniquely cause direct lymphoma cytotoxicity. To improve the delivery and efficacy of CpGs, we utilized a tri-ethylene modified CpG conjugated gold nanoparticle (tmCpG NP) platform that is compatible with both class B and class C CpGs, to treat … WebMar 28, 2024 · Then, 2 μL Cy5-CpG 1826 (Cy5-TCCATGACGTTCCTGACGTT, 1 μM, GenScript, China) was added into the cultured medium and incubated for another 4 h [39,40]. The excessive Cy5-CpG 1826 was removed by washing with PBS for 3 times before the addition of FITC labeled PDA NPs (50 μg/mL) or not. WebDec 3, 2013 · With only 4 μg CpG, NP-CpG-B could substantially protect mice from syngeneic tumor challenge, even after 4 mo of vaccination, compared with free CpG-B. Together, these results show that nanocarriers can enhance vaccine efficacy at a low adjuvant dose for inducing potent and long-lived cellular immunity. Publication types nit orz codeforces solution